Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.36 USD | +7.19% | +1.03% | +13.31% |
05-09 | Transcript : Phathom Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Phathom Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.31% | 566M | |
+29.65% | 48.16B | |
-0.57% | 41.73B | |
+42.66% | 41.03B | |
-5.26% | 28.77B | |
+10.13% | 25.59B | |
-22.61% | 18.96B | |
+9.07% | 12.92B | |
+29.25% | 12.03B | |
-1.82% | 11.77B |
- Stock Market
- Equities
- PHAT Stock
- News Phathom Pharmaceuticals, Inc.
- Phathom Pharmaceuticals Says US FDA Approves Reformulation of Vonoprazan Tablets for Helicobacter Pylori Infection